These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
697 related articles for article (PubMed ID: 33388022)
21. Endothelial Dysfunction as a Primary Consequence of SARS-CoV-2 Infection. Mezoh G; Crowther NJ Adv Exp Med Biol; 2021; 1321():33-43. PubMed ID: 33656711 [TBL] [Abstract][Full Text] [Related]
22. Increased Risk of COVID-19 in Patients with Diabetes Mellitus-Current Challenges in Pathophysiology, Treatment and Prevention. Gęca T; Wojtowicz K; Guzik P; Góra T Int J Environ Res Public Health; 2022 May; 19(11):. PubMed ID: 35682137 [TBL] [Abstract][Full Text] [Related]
23. Could a family history of type 2 diabetes be a risk factor to the endothelial damage in the patient with COVID-19? Alvarado-Vasquez N Med Hypotheses; 2021 Jan; 146():110378. PubMed ID: 33189452 [TBL] [Abstract][Full Text] [Related]
24. Low plasma angiotensin-converting enzyme 2 level in diabetics increases the risk of severe COVID-19 infection. Zhang Y; Sun Y; Liu K; Alolga RN; Xu X; Feng G; Xiao P Aging (Albany NY); 2021 May; 13(9):12301-12307. PubMed ID: 33962399 [TBL] [Abstract][Full Text] [Related]
25. SARS-CoV-2 infection in patients with diabetes mellitus and hypertension: a systematic review. Deravi N; Fathi M; Vakili K; Yaghoobpoor S; Pirzadeh M; Mokhtari M; Fazel T; Ahsan E; Ghaffari S Rev Cardiovasc Med; 2020 Sep; 21(3):385-397. PubMed ID: 33070543 [TBL] [Abstract][Full Text] [Related]
26. Extremely high-dose insulin requirement in a diabetic patient with COVID-19: a case report. Jornayvaz FR; Assouline B; Pugin J; Gariani K BMC Endocr Disord; 2020 Oct; 20(1):155. PubMed ID: 33066762 [TBL] [Abstract][Full Text] [Related]
27. COVID-19 and Diabetes. Singh AK; Khunti K Annu Rev Med; 2022 Jan; 73():129-147. PubMed ID: 34379444 [TBL] [Abstract][Full Text] [Related]
28. Incretin-Based Therapies Role in COVID-19 Era: Evolving Insights. Stoian AP; Papanas N; Prazny M; Rizvi AA; Rizzo M J Cardiovasc Pharmacol Ther; 2020 Nov; 25(6):494-496. PubMed ID: 32618198 [TBL] [Abstract][Full Text] [Related]
29. Diabetes in the COVID-19 pandemic era. Bonansea TCP; Santos LPD; Zintl K; Souza ACDS Rev Assoc Med Bras (1992); 2021; 67Suppl 1(Suppl 1):157-162. PubMed ID: 34406303 [TBL] [Abstract][Full Text] [Related]
30. COVID-19 in Relation to Hyperglycemia and Diabetes Mellitus. Al-Kuraishy HM; Al-Gareeb AI; Alblihed M; Guerreiro SG; Cruz-Martins N; Batiha GE Front Cardiovasc Med; 2021; 8():644095. PubMed ID: 34124187 [TBL] [Abstract][Full Text] [Related]
31. Endothelial activation and dysfunction in metabolic syndrome, type 2 diabetes and coronavirus disease 2019. Hayden MR J Int Med Res; 2020 Jul; 48(7):300060520939746. PubMed ID: 32722979 [TBL] [Abstract][Full Text] [Related]
32. Kallikrein-kinin blockade in patients with COVID-19 to prevent acute respiratory distress syndrome. van de Veerdonk FL; Netea MG; van Deuren M; van der Meer JW; de Mast Q; Brüggemann RJ; van der Hoeven H Elife; 2020 Apr; 9():. PubMed ID: 32338605 [TBL] [Abstract][Full Text] [Related]
34. The underlying mechanisms for severe COVID-19 progression in people with diabetes mellitus: a critical review. Figueroa-Pizano MD; Campa-Mada AC; Carvajal-Millan E; Martinez-Robinson KG; Chu AR AIMS Public Health; 2021; 8(4):720-742. PubMed ID: 34786431 [TBL] [Abstract][Full Text] [Related]
35. New onset diabetes, type 1 diabetes and COVID-19. Boddu SK; Aurangabadkar G; Kuchay MS Diabetes Metab Syndr; 2020; 14(6):2211-2217. PubMed ID: 33395782 [TBL] [Abstract][Full Text] [Related]
36. Impact of diabetes mellitus on in-hospital mortality in adult patients with COVID-19: a systematic review and meta-analysis. Kaminska H; Szarpak L; Kosior D; Wieczorek W; Szarpak A; Al-Jeabory M; Gawel W; Gasecka A; Jaguszewski MJ; Jarosz-Chobot P Acta Diabetol; 2021 Aug; 58(8):1101-1110. PubMed ID: 33778910 [TBL] [Abstract][Full Text] [Related]
37. Understanding the Co-Epidemic of Obesity and COVID-19: Current Evidence, Comparison with Previous Epidemics, Mechanisms, and Preventive and Therapeutic Perspectives. Dalamaga M; Christodoulatos GS; Karampela I; Vallianou N; Apovian CM Curr Obes Rep; 2021 Sep; 10(3):214-243. PubMed ID: 33909265 [TBL] [Abstract][Full Text] [Related]
38. The Impact of Deranged Glucose Metabolism and Diabetes in the Pathogenesis and Prognosis of the Novel SARS-CoV-2: A Systematic Review of Literature. Ukwenya VO; Adelakun SA; Fuwape TA; Adeagbo AS Curr Diabetes Rev; 2022; 18(3):e060821195355. PubMed ID: 34365925 [TBL] [Abstract][Full Text] [Related]
39. Factors leading to high morbidity and mortality of COVID-19 in patients with type 2 diabetes. Rajpal A; Rahimi L; Ismail-Beigi F J Diabetes; 2020 Dec; 12(12):895-908. PubMed ID: 32671936 [TBL] [Abstract][Full Text] [Related]
40. Diabetes Mellitus during the Pandemic Covid-19: Prevalence, Pathophysiology, Mechanism, and Management: An updated overview. Rais N; Ahmad R; Ved A; Parveen K; Ishrat T; Prakash O; Shadab M; Bari DG; Siddiqui NA Curr Diabetes Rev; 2022; 18(3):e120721194712. PubMed ID: 34931983 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]